Vitamin D Receptor antibody | knockout validation | Abcam ab109234

This is a knockout-validated antibody summary, based on the publication "VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Vitamin D Receptor antibody | knockout validation | Abcam ab109234 figure 1
Figure 1. Western blots analysis of GPX4 and VDR in renal tissue lysates from these four groups. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: Vitamin D Receptor

Catalog number: ab109234

Summary: Rabbit monoclonal IgG against a synthetic peptide within Human Vitamin D Receptor (aa 1-100). Reacts with mouse, rat and human. Suitable for western blot, immunoprecipitation, and chromatin IP. Unsuitable for flow cytometry, immunocytochemistry/immunofluorescence or immunohistochemistry (paraffin).

Validation Method

Western blot

Sample

Wild type and VDR-KO mice renal tissues.

Blocking agent

WB: 0.1% (w/v) BSA solution on a shaker for 2 h.

Primary incubation

WB: at 4 °C for one night.

Secondary incubation

WB: Fluorescent secondary antibody for 1 h.

References
  1. Hu Z, Zhang H, Yi B, Yang S, Liu J, Hu J, et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell Death Dis. 2020;11:73 pubmed publisher